During the review period, the pharmacies channel has been soaring due to an expanding product range and a shift from being a strictly OTC channel to a hybrid of OTC and self-service sales. An important part of this trend has been the introduction of a wider range of personal care products and cosmeceuticals (personal care mimicking pharmaceuticals), some even exclusively marketed through the pharmacy channel, for example the Vichy and Avène brands.
Vaginal antifungals is the highest value growth format in dermatologicals in Bosnia-Herzegovina during 2018. The same is true for the entire review period.
The largest category in dermatologicals in Bosnia-Herzegovina is antipruritics, which are dominantly positioned as products for tackling issues with veins and capillary inflammation. This particular health issue is on the rise in the country as obesity rates are peaking, largely due to a shift from fresh food to packaged food and a sedentary lifestyle that has become a norm during the past two decades.
Bayer Pharma doo and Hemofarm doo lead dermatologicals with a comfortable margin, the only players recording double-digit value shares in the format during 2018. Both players have more than one brand in the top ten in dermatologicals.
Hemofarm recorded the biggest increase in value share in dermatologicals in Bosnia-Herzegovina during 2018. Most of this growth is generated by the Panthenol brand, which is an antipruritic associated with a wide array of applications.
The most successful new product launch in dermatologicals at the end of the review period, or rather a re-launch in this case, is the haemorrhoid treatment brand Faktu by Takeda Pharmaceuticals BH doo. Its swift success is largely due to strong promotional support aimed at key influencers, primarily pharmacists, who are often asked by consumers to make a recommendation.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Medicated Skin Care industry in Bosnia and Herzegovina with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Medicated Skin Care industry in Bosnia and Herzegovina, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Medicated Skin Care research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page